These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18688177)

  • 1. D609, an inhibitor of phosphatidylcholine-specific phospholipase C, inhibits group IV cytosolic phospholipase A2.
    Kang MS; Jung SY; Jung KM; Kim SK; Ahn KH; Kim DK
    Mol Cells; 2008 Nov; 26(5):481-5. PubMed ID: 18688177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role of phosphatidylcholine-specific phospholipase C in regulating leukotriene synthesis and degranulation in human eosinophils.
    Sano A; Sano H; Iwanaga T; Tohda Y
    Eur J Pharmacol; 2020 Oct; 884():173353. PubMed ID: 32707189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
    Abalsamo L; Spadaro F; Bozzuto G; Paris L; Cecchetti S; Lugini L; Iorio E; Molinari A; Ramoni C; Podo F
    Breast Cancer Res; 2012 Mar; 14(2):R50. PubMed ID: 22429397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. fMLP-induced arachidonic acid release in db-cAMP-differentiated HL-60 cells is independent of phosphatidylinositol-4, 5-bisphosphate-specific phospholipase C activation and cytosolic phospholipase A(2) activation.
    Sternfeld L; Thévenod F; Schulz I
    Arch Biochem Biophys; 2000 Jun; 378(2):246-58. PubMed ID: 10860542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.
    Adibhatla RM; Hatcher JF; Gusain A
    Neurochem Res; 2012 Apr; 37(4):671-9. PubMed ID: 22101393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C.
    Amtmann E
    Drugs Exp Clin Res; 1996; 22(6):287-94. PubMed ID: 9034754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and phospholipase C inhibitory activity of D609 diastereomers.
    González-Roura A; Casas J; Llebaria A
    Lipids; 2002 Apr; 37(4):401-6. PubMed ID: 12030321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylcholine-specific phospholipase C regulates thapsigargin-induced calcium influx in human lymphocytes.
    Nofer JR; Tepel M; Walter M; Seedorf U; Assmann G; Zidek W
    J Biol Chem; 1997 Dec; 272(52):32861-8. PubMed ID: 9407064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
    Singh AT; Radeff JM; Kunnel JG; Stern PH
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):201-8. PubMed ID: 11018472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D609-phosphatidylcholine-specific phospholipase C inhibitor attenuates thapsigargin-induced sodium influx in human lymphocytes.
    Nofer JR; Junker R; Seedorf U; Assmann G; Zidek W; Tepel M
    Cell Signal; 2000 May; 12(5):289-96. PubMed ID: 10822169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?
    Luberto C; Hannun YA
    J Biol Chem; 1998 Jun; 273(23):14550-9. PubMed ID: 9603970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner.
    Ito J; Nagayasu Y; Ueno S; Yokoyama S
    J Biol Chem; 2002 Nov; 277(47):44709-14. PubMed ID: 12228236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis.
    Kiss Z; Tomono M
    Biochim Biophys Acta; 1995 Oct; 1259(1):105-8. PubMed ID: 7492608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609).
    Tschaikowsky K; Meisner M; Schönhuber F; Rügheimer E
    Br J Pharmacol; 1994 Nov; 113(3):664-8. PubMed ID: 7532078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609).
    Girón-Calle J; Srivatsa K; Forman HJ
    J Pharmacol Exp Ther; 2002 Apr; 301(1):87-94. PubMed ID: 11907161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of PLA2, PLC, and PLD in bradykinin-induced release of arachidonic acid in MDCK cells.
    Kennedy CR; Proulx PR; Hébert RL
    Am J Physiol; 1996 Oct; 271(4 Pt 1):C1064-72. PubMed ID: 8897811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylcholine-specific phospholipase C and RhoA are involved in the thyrotropin-induced activation of phospholipase D in FRTL-5 thyroid cells.
    Kim JH; Kim SW; Jung PJ; Yon C; Kim SC; Han JS
    Mol Cells; 2002 Oct; 14(2):272-80. PubMed ID: 12442901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Is the True Structure of D609, a Widely Used Lipid Related Enzyme Inhibitor?
    Kato M; Hammam MA; Taniguchi T; Suga Y; Monde K
    Org Lett; 2016 Feb; 18(4):768-71. PubMed ID: 26854352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts.
    van Dijk MC; Muriana FJ; de Widt J; Hilkmann H; van Blitterswijk WJ
    J Biol Chem; 1997 Apr; 272(17):11011-6. PubMed ID: 9110992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylmercury-induced toxicity is mediated by enhanced intracellular calcium through activation of phosphatidylcholine-specific phospholipase C.
    Kang MS; Jeong JY; Seo JH; Jeon HJ; Jung KM; Chin MR; Moon CK; Bonventre JV; Jung SY; Kim DK
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):206-15. PubMed ID: 16854443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.